Performance limitations and participation restrictions among childhood cancer survivors treated with hematopoietic stem cell transplantation - The bone marrow transplant survivor study

被引:52
作者
Ness, KK [1 ]
Bhatia, S
Baker, KS
Francisco, L
Carter, A
Forman, SJ
Robison, LL
Rosenthal, J
Gurney, JG
机构
[1] Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA
[2] City Hope Natl Med Ctr, Duarte, CA 91010 USA
来源
ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE | 2005年 / 159卷 / 08期
关键词
D O I
10.1001/archpedi.159.8.706
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Background: Hematopoietic stem cell transplantation (HCT) may result in important disease- and treatment-related late effects. This study estimated physical, emotional, and educational limitations (performance limitations) and restrictions in the ability to perform personal care or routine daily activities (physical participation restrictions) and restrictions in the ability to participate in social roles (social participation restrictions) in a cohort of cancer survivors treated with HCT during childhood. Methods: Study participants included 235 persons who had a malignancy or hematologic disorder, were treated with HCT before the age of 21 years, and survived at least 2 years after transplantation. A comparison group was recruited and frequency matched for age, sex, and ethnicity. Medical data were abstracted, and patients or parents (if < 18 years at survey completion) completed a mailed 24-page questionnaire. Results: Adult survivors of childhood cancer were morelikely than the comparison group to report limitations in physical (prevalence odds ratio [OR], 2.2; 95% confidence interval [CI], 1.3-3.7) and emotional domains (OR, 2.9; 95% CI, 1.4-5.8) and to report physical participation restrictions (OR, 3.9; 95% CI, 1.9-8.2). Adult survivors were also less likely than the comparison group to be married (OR, 0.4; 95% CI, 0.2-0.6). Child survivors were more likely than similarly aged children to have participated in special education (OR, 3.0; 95% CI, 1.56.0), to report physical participation restrictions (OR, 10.8; 95% CI, 2.2-53.9), and to have behaviors that indicated impaired social competence (OR, 2.0; 95% CI, 0.9-4.2). Conclusion: This study demonstrated that persons treated with HCT as children were at increased risk for performance limitations that restricted participation in routine daily activities and interpersonal relationships.
引用
收藏
页码:706 / 713
页数:8
相关论文
共 40 条
[31]   Study design and cohort characteristics of the childhood cancer survivor study: A multi-institutional collaborative project [J].
Robison, LL ;
Mertens, AC ;
Boice, JD ;
Breslow, NE ;
Donaldson, SS ;
Green, DM ;
Li, FP ;
Meadows, AT ;
Mulvihill, JJ ;
Neglia, JP ;
Nesbit, ME ;
Packer, RJ ;
Potter, JD ;
Sklar, CA ;
Smith, MA ;
Stovall, M ;
Strong, LC ;
Yasui, Y ;
Zeltzer, LK .
MEDICAL AND PEDIATRIC ONCOLOGY, 2002, 38 (04) :229-239
[32]  
SAHLER OJZ, 1994, J DEV BEHAV PEDIATR, V15, P353
[33]  
Sattler J. M., 2001, ASSESSMENT CHILDREN
[34]   Risk factors in the adjustment of siblings of children with cancer [J].
Sloper, P ;
While, D .
JOURNAL OF CHILD PSYCHOLOGY AND PSYCHIATRY, 1996, 37 (05) :597-607
[35]   NEUROPSYCHOLOGICAL DEFICITS IN VERY YOUNG BONE-MARROW TRANSPLANT RECIPIENTS [J].
SMEDLER, AC ;
BOLME, P .
ACTA PAEDIATRICA, 1995, 84 (04) :429-433
[36]   TOTAL-BODY IRRADIATION - A NEUROPSYCHOLOGICAL RISK FACTOR IN PEDIATRIC BONE-MARROW TRANSPLANT RECIPIENTS [J].
SMEDLER, AC ;
NILSSON, C ;
BOLME, P .
ACTA PAEDIATRICA, 1995, 84 (03) :325-330
[37]   Long-term survival and late deaths after allogeneic bone marrow transplantation [J].
Socié, G ;
Stone, JV ;
Wingard, JR ;
Weisdorf, D ;
Henslee-Downey, PJ ;
Bredeson, C ;
Cahn, JY ;
Passweg, JR ;
Rowlings, PA ;
Schouten, HC ;
Kolb, HJ ;
Klein, JP .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (01) :14-21
[38]   Quality of life following bone marrow transplantation: A comparison of patient reports with population norms [J].
Sutherland, HJ ;
Fyles, GM ;
Adams, G ;
Hao, Y ;
Lipton, JH ;
Minden, MD ;
Meharchand, JM ;
Atkins, H ;
Tejpar, I ;
Messner, HA .
BONE MARROW TRANSPLANTATION, 1997, 19 (11) :1129-1136
[39]  
SYRJALA KL, 1993, BONE MARROW TRANSPL, V11, P319
[40]  
Wingard John R., 1998, Current Opinion in Oncology, V10, P108, DOI 10.1097/00001622-199803000-00004